Aldeyra Therapeutics (ALDX) P/E (2014 - 2026)
Aldeyra Therapeutics (ALDX) P/E from Jun 30, 2014 to Jul 21, 2026. The TTM Aldeyra Therapeutics (ALDX) P/E is -3.85. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Aldeyra Therapeutics (ALDX)
| Year | P/E | Change |
|---|---|---|
| 2026 | -3.85 | -58.19% |
| 2025 | -9.20 | +72.94% |
| 2024 | -5.32 | +17.75% |
| 2023 | -4.52 | -27.81% |
| 2022 | -6.26 | +112.36% |
| 2021 | -2.95 | -53.45% |
| 2020 | -6.33 | +142.15% |
| 2019 | -2.61 | -43.91% |
| 2018 | -4.66 | -9.72% |
| 2017 | -5.16 | +62.61% |
| 2016 | -3.17 | -37.46% |
| 2015 | -5.07 | -28.29% |
| 2014 | -7.08 | N/A |
Comparison Aldeyra Therapeutics (ALDX) P/E with competitors
Aldeyra Therapeutics (ALDX) P/E is -3.85.